Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 14.32 is 30% above its 5-year average of 11.03, around the middle of its 5-year range (0.00–31.96).
As of the fiscal period ended Tuesday, June 30, 2026. 8.44% below its 12-month average of 15.64.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.32.
QUICK RATIO (ACID-TEST)
14.32
QUICK RATIO (ACID-TEST) AVG TTM
15.64
QUICK RATIO (ACID-TEST) AVG 3Y
9.46
QUICK RATIO (ACID-TEST) AVG 5Y
11.03
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.44%
CURRENT VS 3Y AVG
+51.35%
CURRENT VS 5Y AVG
+29.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 795 covered companies
CURRENT VS SECTOR MEDIAN
+336.66%
vs the sector median at left
AN2 Therapeutics, Inc.
Market Cap
$185.30M
Quick Ratio (Acid-Test)
14.32
TTM Avg
15.64
3Y Avg
9.46
5Y Avg
11.03
Market Cap
$185.48M
Quick Ratio (Acid-Test)
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
Market Cap
$181.71M
Quick Ratio (Acid-Test)
4.98
TTM Avg
16.09
3Y Avg
15.64
5Y Avg
15.37
Market Cap
$189.50M
Quick Ratio (Acid-Test)
7.90
TTM Avg
9.91
3Y Avg
10.86
5Y Avg
18.34
Market Cap
$176.97M
Quick Ratio (Acid-Test)
15.26
TTM Avg
8.44
3Y Avg
8.43
5Y Avg
6.74
Market Cap
$175.86M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.25
3Y Avg
1.14
5Y Avg
1.20
Market Cap
$192.08M
Quick Ratio (Acid-Test)
3.61
TTM Avg
10.13
3Y Avg
8.61
5Y Avg
9.32
Market Cap
$176.31M
Quick Ratio (Acid-Test)
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
Market Cap
$173.00M
Quick Ratio (Acid-Test)
3.49
TTM Avg
3.52
3Y Avg
4.49
5Y Avg
5.44
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | $185.30M | 14.32 | 15.64 | 9.46 | 11.03 |
| Canton Strategic Holdings Inc (CNTN)vs › | $185.48M | 15.70 | 3.42 | 4.67 | 3.16 |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.71M | 4.98 | 16.09 | 15.64 | 15.37 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.50M | 7.90 | 9.91 | 10.86 | 18.34 |
| Yarrow Bioscience Inc (YARW)vs › | $176.97M | 15.26 | 8.44 | 8.43 | 6.74 |
| Journey Medical Corporation (DERM)vs › | $175.86M | 1.41 | 1.25 | 1.14 | 1.20 |
| RxSight, Inc. (RXST)vs › | $192.08M | 3.61 | 10.13 | 8.61 | 9.32 |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.31M | 11.22 | 14.99 | 15.44 | 13.43 |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.00M | 3.49 | 3.52 | 4.49 | 5.44 |
| Precision BioSciences, Inc. (DTIL)vs › | $172.23M | 12.82 | 9.83 | 6.43 | 5.45 |
Quick Ratio
14.32
Excludes inventory
Current Ratio
14.32
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 14.32 |
| 2026-03-31 | 15.73 |
| 2025-12-31 | 6.87 |
| 2025-09-30 | 9.33 |
| 2025-06-30 | 31.96 |
| 2025-03-31 | 8.68 |
| 2024-12-31 | 8.43 |
| 2024-09-30 | 9.75 |
| 2024-06-30 | 10.61 |
| 2024-03-31 | 10.91 |
| 2023-12-31 | 7.87 |
| 2023-09-30 | 8.52 |
| 2023-06-30 | 8.80 |
| 2023-03-31 | 10.54 |
| 2022-12-31 | 13.72 |
| 2022-09-30 | 24.21 |
| 2022-06-30 | 28.17 |
| 2022-03-31 | 23.55 |
| 2021-12-31 | 17.70 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
